Biomolecular imaging for 21 CFR Part 11 and EU GMP Annex 11 regulated environments
Imaging systems are a ubiquitous part of gel and Western blotting workflows. Images generated by imaging systems enable you to determine the purity of drug samples, identify the presence or absence of biomolecules, and monitor changes in expression. Today, it is easy to edit images using widely available software tools. So, how can you protect your images and trace their history?
• Cytiva’s 21 CFR Part 11 imaging systems and software that offer special data protection and tamper prevention tools together with event logs, and
• Features that can help secure your imaging data in a regulated environment.
Erik Bjerneld, PhD, Senior Scientist, Imaging and Western Blotting, Cytiva
Erik is a physical chemist with a background in spectroscopy, imaging, and electrophoresis. He joined Amersham Biosciences, now Cytiva, in 2003, where for the past five years his focus has been the development of scanners and CCD imagers. Erik received his PhD in Materials Science from Chalmers University of Technology, Sweden.